since dibutyryl cyclic A M P also stimulates cell growth. T h e mcchanism is unknown; however. other workers. e.g. Rozengurt e/ ( I / . (261 reported that a sustained increase in cellular cyclic A M P acts as ii mitogenic signal for Swiss 3T3 cells. There is also a report 1271 that the catalytic subunit of cyclic A MP-dependent protein kinase may be involved in regulation o f the proto-oncogene, c-fos.
From this work. it seems that p-agonists have two actions: in the short-term they stimulate rcnin release. probably through increased rate o f exocytosis o r rcnin gene expression: longer-term administration o f isoprenaline (or dibutyryl cyclic A M P ) also led t o an increased number o f renin-secreting cells and consequently a sustained and long-term increase in renin release. This finding could be applicable t o other mammalian hormones, namely agonists effective in the short-term may have a dual role as growth factors on the hormone-secreting target cell. allowing a sustained hormone response t o increased demand.
However. in conclusion. it is as yet not known whether the growth-promoting cffccts o f B-agonists have clinical relevance in ncphroblastoma. There is increasing evidence that neuroexcitatory amino acids (in particular those related to glutamate) have a cytotoxic action on central nervous system (CNS) neurons both iir i i i w and iir ii/ro and this may play a mediating role in the pathogenesis of neurological degenerative diseases such as Alzheimer's ( A D ) and motor neuronc disease (MND). In patients with MND. for example, there are raised levels of glutamate, aspartate and glycine in the cerebrospinal fluid In patients with A D there is evidence o f a reduced cortical glutamate concentration (41. together with an impairment in glutamate transmission, as judged by reduced receptor hinding for NMDA and quisqualate in the hippocampal region
[S]. T h e putative involvement of excitatory amino acids in
A D has also been demonstrated in animal studies. Ibotenic acid (an NMDA agonist)-induced lesions of the nucleus basalis of Meynert in rabbits results in ncuronal atrophy, the formation of plaques and tangles and a reduction in cholinergic input to the cortex 161. Similar studies in rats have shown that y-aminobutyric acid ( G A B A ) neuron depletion, which is characteristic of Huntington's chorea, can be mimicked by striatal lesioning with quinolinic acid 17 1.
Thus it would appear that amino acid neurotransmitters, in particular those related to activation of glutamatc receptor subtypes, may play a causative role in neurodengeneration.
In this study, a rat cerebral culture system has been used to investigate the action of excitatory and inhibitory amino acids on somatostatin (SRIF) activity (SRIF is severely depleted in the brains of A D patients) 18, 91. Fetal rat (17 day) cortical and hypothalamic cultures were prepared as previously described and plated at a seeding density o f 5 x lo5 cells/cm2 into 24-well tissue culture dishes prctreated with poly-D-lysine ( 100 pg/ml) I 101. After an initial incubation (16 h ) in a-minimal essential medium containing Vol. 18 BIOCHEMICAL SOCIETY TRANSACTIONS 5% (v/v) fetal calf serum and 25 mM-KCI, the cells were washed extensively in Earle's balanced salt solution and then incubated for a further 7 days in serum-free supplemented F12/Dulbecco's-modified Eagle's medium [ 1 11 . Experiments were performed in serum-free supplemented media, free of the amino acids, aspartate, glutamine and glycine. SRlF was measured by specific radioimmunoassay [ 121.
In cortical cell cultures treated for up to 96 h, NMDA ( 1 0 -j~) showed a time-dependent stimulation of SRlF (intracellular + secreted) activity. This was only apparent at time points beyond 24 h of incubation, suggesting that the net increase in levels may be due to synthesis de novo ( Table  1) . In contrast to the stimulatory action of NMDA, kainic acid and quisqualate, at the same concentration, both produced inhibitory SRIF responses ( Table 1 ) . Glutamic acid which has agonist action at all three receptor subtypes had a net inhibitory action on SRlF levels. All four amino acids, glutamate, NMDA, kainic acid and quisqualate produced parallel responses in the hypothalamic cultures (results not shown). When NMDA was co-incubated with either kainic acid or quisqualate, the NMDA stimulatory action on SRlF was completely abolished.
Analysis of SRlF release showed that NMDA stimulated secretion (180-220%) of basal) at all the time points ( 12-96 h) investigated. On the other hand, glutamate, kainic acid and quisqualate inhibited SRlF release (50-70% of basal after 96 h of inubation); at shorter incubation times ( < 10 h), however, a stimulation of release was seen similar to that reported by Tapia-Arancibia 1131. The reduced SRlF release in response to glutamic acid, kainic acid and quisqualate may reflect the decreased intracellular levels which were observed as early as 4 h (Fig. 1) . The behaviour of NMDA o n intracellular SRlF levels is clearly different from the other three amino acids, since levels were either no different from control (48 h) or elevated (140-180% of basal) (96 h; data not shown); inhibition, however, was seen up to 24 h.
In all of the above experiments, the amino acids were used at a single concentration ( 1 OV'M). When dose-related experiments (lo-'-1 V 3~) were performed, NMDA and kainic acid had a biphasic action on intracellular SRlF levels in both hypothalamic and cortical cells. Glutamate and quisqualate, on the other hand, showed only a dose-related inhibition (25-50% of basal at 10Y'~). NMDA ( 1 0 F '~) stimulated intracellular SRlF (2-300'% of basal), whereas a concentration of I 0 3~ caused a marked inhibition (40-60% of basal) (Fig. 2) . In the same experiment, released SRlF levels followed a similar pattern to the intracellular levels: the release values in response to IOV3~-NMDA were markedly less than that seen at 1 0 -5~ (Fig. 2) . A similar biphasic action was seen with kainic acid; a concentration o f I 0 'M stimulated intracellular levels ( I SO-200'%) of basal), while a 10-fold higher concentration reduced levels to Of the two major inhibitory amino acids in the CNS, glycinc ( 10 ~ J~) stimulated intracellular SRlF (225-300% of basal); secreted levcls were. however. not significantly altered. G A B A which can be converted endogenously from glutamate in neuronal axons. did not affect either intracellular or secreted SRIF.
Preliminary experiments indicated that NMDA stimulation of SRlF release could not be inhibited by pretreatment and co-incubation with competitive antagonist, 2-amino-Sphosphonopentanoic acid (D-APS), but subsequent experiments using a higher dose (5 . This latter finding, together with the fact that glycine can stimulate intracellular SRIF, suggests that the stimulatory action of NMDA on SRlF release may. iit least in part, be mediated through the glycine allosteric regulatory site o f the NMDA receptor. A s expected neithcr D-APS nor MKXO I prevented the inhibitory action of kainic acid on SRIF levels; surprisingly, however, the selective kainic acid/quisqualate antagonist, y-glutamyltaurinc also had no effect. This latter result is consistent with that reported previously [ 131.
A number o f reports 114. IS1 have suggcsted that a putative action of excitatory amino acids is mediation through the inositol phospholipid pathway. Our results show that addition of either glutamate o r quisqualate t o cortical or hypothalamic cells prelabelled with niy~-[~H]inositol caused a rapid accumulation o f labelled inositol phosphates (glutamate. I80 k 10% basal; quisqualate. 165 f 10%) of basal). Kainic acid was much less potent ( 125 k S' Yo of basal) and NMDA showed virtually no activity. These results are similar to those obtained by Schoepp [ 141. T h e lack o f effect of NMDA on inositol phospholipid turnover may be due to the presence of Mg'+ in our incubating media. Mg2+ has been shown t o inhibit NMDA, but not kainic acid or quisqualate potentiation of inositol phospholipid turnover [ 151. Whether excitatory amino acid stimulation o r inhibition of SRlF activity is mediated through the inositol phospholipid pathway is unclear. Our initial experiments with staurosporine ( a potent protein kinase C inhibitor) 1161 failed t o reduce the stiniulntory action o f NMDA o r the inhibitory action of kainic acid on SRlF rclcase.
In summary. our data show that rat cortical and hypothalamic SKlF can be regulated by activation of glutamate and glycinc receptors. T h e mechanisms of action o f the functional link between amino acids and SRlF remains to be determined. Other reports have suggested that excitatory amino acids can inhibit stimulated inositol phospholipid turnover I 171. and NMDA. but not kainic acid o r quisqualatc. can activate the arachidonic acid cascade system I I SI. Nevertheless. the biphasic action of NMDA and kainic acid on SRlF levels is consistent with the hypothesis that excitatory amino acids under normal circumstances play ;I transmitter role. but have a neurotoxic action when they are present in high concentration.
20-50'%) o f basal.
T h e putative accumulation of excitatory amino acids in neurodegenerativc diseases may occur as a result of damage t o the neuron support cells, the glial astrocytes. T h e primary cause o f this damage is, however. unclear. Since the astrocytcs arc major sites of glutamate metabolism. their impairment may lead to the accumulation o f glutamate and harmful ammonia and a loss o f important neurotropic factors. thus ultimately leading to neurotoxicity (for a review. see Il9l). Furthermore. there is evidence t o suggest the presence o f neurotoxic molecules in sera o f patients with Huntington's chorea [ 2 0 ] and in M N D (M.D. Lewis, personal communication) . Although the natures o f such molecules are as yet undetcrmincd. their toxicity may well be mediated through actions at excitatory amino acid receptors. Finally, investigations into antagmists which may reverse the excitatory amino acid action o f SRlF may provide a basis for new rational therapies in neurological diseases, in particular A D .
